CytoSorbents Corporation Announces Virtual Annual Meeting of Stockholders on June 6, 2024
Ticker: CTSO · Form: DEF 14A · Filed: Apr 19, 2024 · CIK: 1175151
| Field | Detail |
|---|---|
| Company | Cytosorbents CORP (CTSO) |
| Form Type | DEF 14A |
| Filed Date | Apr 19, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 20 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: Proxy Statement, Annual Meeting, Virtual Meeting, Stockholder Participation, Cytosorbents
TL;DR
<b>CytoSorbents Corporation will host its Annual Meeting of Stockholders virtually on June 6, 2024, allowing remote participation and electronic voting.</b>
AI Summary
Cytosorbents Corp (CTSO) filed a Proxy Statement (DEF 14A) with the SEC on April 19, 2024. The Annual Meeting of CytoSorbents Corporation stockholders will be held virtually on June 6, 2024, at 10:00 a.m. Eastern Time. Stockholders can attend and vote electronically by visiting www.virtualshareholdermeeting.com/CTSO2024. A 16-digit control number from the proxy card or voting instruction form is required for participation. Online check-in begins at 9:00 a.m. Eastern Time, with the webcast starting promptly at 10:00 a.m. Eastern Time. The company is holding a virtual meeting to facilitate stockholder attendance and participation from any location.
Why It Matters
For investors and stakeholders tracking Cytosorbents Corp, this filing contains several important signals. Holding a virtual meeting allows for broader stockholder participation regardless of geographical location or resources. The virtual format ensures stockholders have the same rights and opportunities to participate as they would at an in-person meeting.
Risk Assessment
Risk Level: low — Cytosorbents Corp shows low risk based on this filing. The filing is a routine DEF 14A proxy statement, indicating standard corporate governance procedures rather than significant operational or financial changes.
Analyst Insight
Stockholders should review the proxy materials and ensure they have their control number ready for participation in the virtual annual meeting on June 6, 2024.
Key Numbers
- 2024-06-06 — Annual Meeting Date (Date of the virtual Annual Meeting of Stockholders.)
- 10:00 AM ET — Meeting Start Time (Scheduled start time for the virtual Annual Meeting webcast.)
- 09:00 AM ET — Check-in Start Time (Time when online check-in for the virtual meeting begins.)
- 0001175151 — Central Index Key (Company's SEC identification number.)
Key Players & Entities
- Cytosorbents Corporation (company) — Registrant and filer of the proxy statement.
- June 6, 2024 (date) — Date of the Annual Meeting of Stockholders.
- 10:00 a.m. Eastern Time (time) — Scheduled start time for the Annual Meeting webcast.
- www.virtualshareholdermeeting.com/CTSO2024 (url) — Website for attending and voting at the virtual Annual Meeting.
- 9:00 a.m. Eastern Time (time) — Time when online check-in for the virtual meeting begins.
FAQ
When did Cytosorbents Corp file this DEF 14A?
Cytosorbents Corp filed this Proxy Statement (DEF 14A) with the SEC on April 19, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Cytosorbents Corp (CTSO).
Where can I read the original DEF 14A filing from Cytosorbents Corp?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Cytosorbents Corp.
What are the key takeaways from Cytosorbents Corp's DEF 14A?
Cytosorbents Corp filed this DEF 14A on April 19, 2024. Key takeaways: The Annual Meeting of CytoSorbents Corporation stockholders will be held virtually on June 6, 2024, at 10:00 a.m. Eastern Time.. Stockholders can attend and vote electronically by visiting www.virtualshareholdermeeting.com/CTSO2024.. A 16-digit control number from the proxy card or voting instruction form is required for participation..
Is Cytosorbents Corp a risky investment based on this filing?
Based on this DEF 14A, Cytosorbents Corp presents a relatively low-risk profile. The filing is a routine DEF 14A proxy statement, indicating standard corporate governance procedures rather than significant operational or financial changes.
What should investors do after reading Cytosorbents Corp's DEF 14A?
Stockholders should review the proxy materials and ensure they have their control number ready for participation in the virtual annual meeting on June 6, 2024. The overall sentiment from this filing is neutral.
Key Dates
- 2024-06-06: Annual Meeting of Stockholders — The company will hold its annual meeting virtually, allowing remote participation and electronic voting.
- 2024-04-19: Filing Date — The date the Definitive Proxy Statement (DEF 14A) was filed with the SEC.
Glossary
- DEF 14A
- Definitive Proxy Statement filed with the SEC. (Indicates the company is providing definitive proxy materials to shareholders for an upcoming meeting.)
- Common Stock
- Shares of stock that represent ownership in a corporation. (The type of stock held by the attendees of the Annual Meeting.)
- Virtual Annual Meeting
- A shareholder meeting conducted online, without a physical location. (The format chosen by Cytosorbents for its 2024 Annual Meeting to enhance accessibility.)
Filing Stats: 4,876 words · 20 min read · ~16 pages · Grade level 12.1 · Accepted 2024-04-19 16:45:24
Key Financial Figures
- $0.001 — ommon stock, each having a par value of $0.001 per share (“ Common Stock ”
Filing Documents
- tm243005d1_def14a.htm (DEF 14A) — 763KB
- tm243005d1_def14aimg001.jpg (GRAPHIC) — 119KB
- tm243005d1_def14aimg002.jpg (GRAPHIC) — 151KB
- tm243005d1_img001.jpg (GRAPHIC) — 229KB
- 0001104659-24-049498.txt ( ) — 1453KB
From the Filing
DEF 14A 1 tm243005d1_def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under §240.14a-12 CYTOSORBENTS CORPORATION (Name of Registrant as Specified in its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. CytoSorbents Corporation 305 College Road East Princeton, NJ 08540 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS NOTICE IS HEREBY GIVEN that the Annual Meeting of the holders of shares of common stock, each having a par value of $0.001 per share (“ Common Stock ”), of CytoSorbents Corporation (“ CytoSorbents ” or the “ Company ”) will be held virtually on Thursday, June 6, 2024 at 10:00 a.m. Eastern Time (the “ Annual Meeting ”). Virtual Annual Meeting The Company’s Board of Directors (the “ Board ”) has determined to hold a virtual annual meeting in order to facilitate stockholder attendance and participation by enabling stockholders to participate from any location and at no cost. We believe this is the right choice for the Company at this time, as it enables engagement with our stockholders, regardless of size, resources, or physical location. We are committed to ensuring that our stockholders will be afforded the same rights and opportunities to participate as they would at an in-person meeting. You will be able to attend the Annual Meeting online and vote your shares electronically during the Annual Meeting by visiting www.virtualshareholdermeeting.com/CTSO2024 . To participate in the virtual Annual Meeting, you will need the 16-digit control number included on your “Notice Regarding Internet Availability of Proxy Materials (the “ Notice ”)” proxy card or voting instruction form. The Annual Meeting webcast will begin promptly at 10:00 a.m. Eastern Time. We encourage you to access the Annual Meeting prior to the start time. Online check-in will begin at approximately 9:00 a.m. Eastern Time, and you should allow ample time for the check-in procedures. We will have technicians ready to assist you with any technical difficulties you may have accessing the virtual Annual Meeting. A phone number where you can obtain technical assistance will be made available on the day of the Annual Meeting. Items of Business At the Annual Meeting, you will be asked to consider and take action with respect to the following: 1. To elect five directors, who shall each serve for a term of one year; 2. To approve, on an advisory basis, the compensation of the Company’s named executive officers, disclosed pursuant to Item 402 of Regulation S-K; 3. To approve an amendment (the “ Plan Amendment ”) to the Amended and Restated CytoSorbents Corporation 2014 Long-term Incentive Plan (the “ Plan ”); 4. To ratify the appointment of WithumSmith+Brown, PC as the Company’s independent registered public accounting firm to audit the Company’s financial statements for the fiscal year ending December 31, 2024; and 5. To conduct such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof. The foregoing items of business are fully described in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders. Only holders of Common Stock of record at the close of business on April 12, 2024 are entitled to notice of, and to vote at, the Annual Meeting or any adjournments or postponements thereof. The Board of Directors recommends that you vote as follows on the matters to be presented at the Annual Meeting: 1. FOR the election of the five nominees to the Board, each for a one-year term. 2. FOR the vote to approve the compensation of the Company’s named executive officers, disclosed pursuant to Item 402 of Regulation S-K, on advisory basis. 3. FOR the approval of the Plan Amendment. 4. FOR the ratification of the appointment of WithumSmith+Brown, PC as our independent registered public accounting firm for the fiscal year ending December 31, 2024. Similar to last year, instead of mailing a printed copy of our proxy materials, including our Annual Report, to each stockholder of record, we have decided to provide access to these materials in a faster and more efficient manner via the Internet. This reduces the amount of paper necessary to produce these materials, as well as the costs